Financhill
Buy
84

LENZ Quote, Financials, Valuation and Earnings

Last price:
$34.57
Seasonality move :
0.13%
Day range:
$32.45 - $35.31
52-week range:
$16.54 - $38.93
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.16x
Volume:
324.9K
Avg. volume:
348.8K
1-year change:
60.25%
Market cap:
$990.5M
Revenue:
--
EPS (TTM):
-$1.77

Earnings Data

Next earnings date for LENZ
Aug 14
2025
Most recent earnings per share
-$0.53
Missed by $0.21
(May 7/2025)
Consensus Estimate
-$0.32
(May 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LENZ Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $3.2M -- -- -$0.65 --
08/14/2025 Q2 $714.3K -- -- -$0.54 --
05/07/2025 Q1 -- -- -$0.53 -$0.32 -$0.21
03/19/2025 Q4 -- -- -$0.46 -$0.40 -$0.06
11/06/2024 Q3 -- -- -$0.38 -$0.43 $0.05
08/14/2024 Q2 -- -- -$0.40 -$0.67 $0.27
03/31/2024 Q1 -- -- -$3.53 -- --
12/31/2023 Q4 -- -- -$0.93 -- --
09/30/2023 Q3 -- -- -$0.74 -- --
03/31/2023 Q1 -- -- -$0.50 -- --
12/31/2022 Q4 -- -- -$0.37 -- --

LENZ Therapeutics Earnings Questions

  • How Much did LENZ Therapeutics Generate in Revenue Last Quarter?

    LENZ Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did LENZ Therapeutics Beat Earnings Last Quarter?

    LENZ Therapeutics announced earnings per share of -$0.53 which represents a miss of analyst forecast a -$0.32 per share.

  • Is LENZ Therapeutics Profitable?

    LENZ Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for LENZ Therapeutics EPS Next Year?

    LENZ Therapeutics's earnings are forecast to decrease from -$2.34 per share to -$1.80 per share next year representing a decrease of -7.69%.

  • When is LENZ Therapeutics's Earnings Date?

    LENZ Therapeutics's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock